PILATESRETURN TO LIFE THROUGH CONTROLOG

Product Information

Tell your doctor or pharmacist straight away. If possible take your medicine and this leaflet with you. There are no known symptoms of overdose. Simptome (de exemplu, pirozis, regurgitarea acidului, dureri la deglutiţie) asociate bolii de reflux gastroesofagian cauzate de refluxul acidului din stomac. jestliže máte sníženou rezervu vitaminu B12 v těle nebo rizikové faktory pro sníženou hladinu vitaminu B12 a užíváte pantoprazol dlouhodobě. Stejně jako všechny přípravky snižující množství kyseliny může pantoprazol vést ke sníženém vstřebávání vitaminu B12.

warfarin či fenprokumon, které mají vliv na houstnutí nebo řídnutí krve (krevní srážlivost). Mohou být nutná další vyšetření. Tell your doctor or pharmacist if you have taken more than the recommended dose. If possible take your medicine and this leaflet with you La pacientii cu insuficienta hepatica severa se va administra 1 tableta de Controloc( 40 mg Pantoprazol) la doua zile. Se va inghiti intreaga tableta, nemestecata si fara a se sparge, cu apa, inaintea sau in timpul micului dejun. Kuehne+Nagel’s integrated ecosystem is the result of over 20 years’ experience at maximising value in our customers’ supply chains and applying these lessons to our service offerings. This ecosystem is enabled by core values and technologies which power our ability to support our customers. Control Tower nemusíte trávit čas komplikovaným vyhledáváním těchto potřebných informací na různých nepřehledných webových stránkách. Stačí zde pouze zadat název léku do políčka vyhledávání, nebo si najít léčivo podle abecedy.

Administrare Controloc 20 mg comprimate gastro-rezistente:

Doza recomandată este de un comprimat pe zi. În cazul în care afecţiunea revine, medicul vă poate dubla doza, situaţie în care puteţi utiliza câte un comprimat de Controloc 40 mg, pe zi. După vindecare, puteţi reduce din nou doza la un comprimat de 20 mg pe zi.

Very rare side effects: disorientation; reduction in the number of blood platelets, which may cause you to bleed or bruise more than normal; reduction in the number of white blood cells, which may lead to more frequent infections. Příbalové letáky na tomto webu obsahují veškeré potřebné informace, ať už se jedná o složení, dávkování a způsob podání, vedlejší účinky nebo o indikace, kontraindikace a další potřebné informace. Balení obsahují 7, 10, 14, 15, 24, 28, 30, 48, 49, 56, 60, 84, 90, 98, 98 (2x49), 100, 112, 168enterosolventních tablet.

Tableta este o modalitate care ii ajuta pe copii sa isi petreaca mai usor timpul liber, datorita multitudinii de jocuri si aplicatii. Pokud vám lékař předepsal denní dávku vyšší než 4 tablety denně, sdělí vám také přesně, kdy máteukončit užívání přípravku.

The CHMP noted that pantoprazole 20 mg was effective in the short-term treatment of reflux symptoms and that there is a long safety experience with the medicine as a prescription medicine. It was also of the opinion that, based on the experience of the use of pantoprazole, the availability of Controloc Control without medical supervision is appropriate. The CHMP therefore decided that Controloc Control’s benefits are greater than its risks and recommended that it be given marketing authorisation. Other information about Controloc Control Další závažné stavy (četnost není známa): zežloutnutí kůže či očního bělma (těžké poškození jaterních buněk, žloutenka) či horečka, vyrážka a zvětšení ledvin někdy s bolestivým močením a bolestmi v kříži (těžký zánět ledvin). BF010 (CSR 298E/99) This study compared the efficacy of omeprazole 10 mg versus pantoprazole 20 mg at day 28 in patients without oesophagitis established by endoscopy. No day 14 data was available in the study report. In the non-prescription product setting, the patient would be self-referring to their physician if no symptomatic relief was obtained by day 14, making this study of limited value in the non-prescription context. Additionally, the usual starting dose for omeprazole in reflux disease is 20 mg; 10 mg omeprazole is not therapeutically equivalent to 20 mg pantoprazole. The study contained a treatment phase C; days 29-56, but again, this is not relevant to a non-prescription indication of no more than 28 days. Overall this study provides no relevant data analogous to the initial non-prescription medication period of up to 14 days. Additionally, in other studies efficacy of pantoprazole was compared to other PPIs (lansoprazole, esomeprazole) and it was found to be non-inferior to these PPIs in relieving symptoms of heartburn and acid regurgitation (Study VMG305 and M3-320). If you have no symptom-relief after taking this medicine for 2 weeks continuously, consult your doctor. Nemocniční balení obsahují 50, 90, 100, 140, 140 (10x14), 150 (10x15), 700 (5x140)enterosolventních tablet.Vždy užívejte přípravek Controloc 40 mg přesně podle pokynů svého lékaře. Pokud si nejste jistý/á,poraďte se se svým lékařem nebo lékárníkem. Dacă suferiţi de afecţiuni hepatice severe, nu trebuie să luaţi mai mult de un comprimat de 20 mg pe zi. Do not take a double dose to make up for the forgotten dose. Take your next, normal dose, the next day, at your usual time. Dacă aveţi afecţiuni hepatice severe. Vă rugăm să informaţi medicul dacă aţi avut vreodată probleme hepatice în trecut. Acesta vă va verifica nivelul enzimelor hepatice mai frecvent, în special dacă luaţi Controloc în cadrul unui tratament de lungă durată. În cazul creşterii nivelului de enzime hepatice, tratamentul trebuie întrerupt. Primary Objective Secondary Objective Treatment Duration Results Study No. CSR No. N ITT 2 weeks 219 BY1023BGSA017 24598 Relief of heartburn in GORD Stage 0 Time to freedom from key GORD symptoms Pan 20, Placebo Pantoprazole was superior to placebo 4 weeks 338 BY1023FK3059 932001 Relief of key symptoms in GORD after 28 days Relief of key symptoms in GORD after 14 days Pan 20, Ran 300 once daily Pantoprazole was superior to ranitidine 4 weeks 356 BY1023VMG306 30298 Relief of symptoms in GORD Stage 0I after 4 weeks of treatment Leading symptom relief after 2 weeks of treatment Pan 20, Ran 150 bid Pantoprazole was superior to ranitidine 4 weeks 375 BY1023VMG305 30198 Pan 20, Lan 15 Relief of symptoms in GORD Stage 0I after 4 weeks of treatment Relief of GORD symptoms after 2 weeks of treatment Pantoprazole was non-inferior to lansoprazole after 4 weeks of treatment Pan 20, 40 4 weeks 421 BY1023M3-316 1522003 Relief of symptoms in GORD Stage A-D Assessment of GI symptoms at day 14 and 28 Pantoprazole was effective and well tolerated 4 weeks 529 BY1023M3-320 1702003 Pan 20, Eso 20 Relief of GORD-related symptoms after 14 and 28 days Time to first symptom relief of GORD-related symptoms in GORD Stage 0 Both PPIs were comparably effective pantoprazole was non-inferior to esomeprazole